NCT05369208 Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP Status COMPLETED Phase PHASE3
NCT05353673 The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT05333744 The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy Status UNKNOWN Phase PHASE2
NCT05302024 Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT05281068 The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT05214391 A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia Status RECRUITING Phase PHASE2
NCT05116423 Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia Status UNKNOWN Phase N/A
NCT05046327 Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months Status WITHDRAWN Phase PHASE3
NCT05023915 A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05020288 A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP Status UNKNOWN Phase PHASE2
NCT04993885 Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies Status RECRUITING Phase PHASE2
NCT04943042 An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP Status COMPLETED Phase N/A
NCT04904276 Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy Status TERMINATED Phase N/A
NCT04800458 Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis Status RECRUITING Phase NA
NCT04747080 The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia Status UNKNOWN Phase PHASE2